Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis

Radiology. 2022 Jun;303(3):544-545. doi: 10.1148/radiol.212340. Epub 2022 Mar 1.

¹ From the Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, 711 Concession St, Hamilton, ON, Canada L8V 1C3 (C.B.v.d.P.); Department of Radiology and Epidemiology, University of Ottawa, Ottawa, ON, Canada (M.D.F.M.); Ottawa Hospital Research Institute Clinical Epidemiology Program, Department of Medical Imaging, The Ottawa Hospital-Civic Campus, Ottawa, ON, Canada (M.D.F.M.); Faculty of Health Sciences, Queen's University, Kingston, ON, Canada (J.P.S.); Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada (J.P.S.); Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (V.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada (A.T.); Departments of Radiology and Medicine and Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.).

Abstract

See also the editorial by Ronot in this issue. Online supplemental material is available for this article.